DTC(直接面對消費者)測試產業:全球市場
市場調查報告書
商品編碼
1487489

DTC(直接面對消費者)測試產業:全球市場

Direct-to-Consumer Testing Industry: Global Markets

出版日期: | 出版商: BCC Research | 英文 81 Pages | 訂單完成後即時交付

價格

全球DTC(直接面對消費者)測試市場規模預計將從2023年的16億美元增加到2029年的32億美元,預測期間內複合年成長率為12.5%。

基因 DTC 檢測產業預計將從 2023 年的 13 億美元增至 2029 年的 27 億美元,複合年成長率為 12.7%。此外,微生物組 DTC 測試領域預計將從 2023 年的 513 億美元增至 2029 年的 1,095 億美元,複合年成長率為 13.7%。

該報告調查了全球DTC(直接面對消費者)測試市場,並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、專利趨勢、市場規模趨勢和預測以及各種資訊。了按細分市場和地區、競爭狀況、主要企業概況等進行的詳細分析。

目錄

第1章執行摘要

  • 市場展望
  • 調查範圍
  • 市場概況

第2章 市場概況

  • 概述
  • PESTEL分析
  • 波特五力分析
  • 產業競爭
  • 監管狀況
  • 美國
  • 歐洲
  • 亞太地區
  • 其他地區

第3章市場動態

  • 市場動態
  • 市場促進因素
  • 消費者和醫生意識不斷增強
  • 降低基因序列分析的成本
  • 市場限制因素
  • 缺乏監管指引
  • 結果不準確
  • 市場機會
  • 新興經濟體
  • 市場挑戰
  • 道德和資料隱私問題

第4章新興科技與發展

  • 新技術
  • 基因序列分析的進展
  • 數位化
  • AI
  • 專利分析
  • 專利:按公司分類

第5章市場區隔分析

  • 按細分市場細分
  • 市場分析:按測試類型
  • 基因DTC測試
  • 基於生物標記的 DTC 測試
  • 微生物組 DTC 測試
  • 市場分析:依應用分類
  • 健康/保健
  • 祖先/家譜
  • 疾病風險評估
  • 職業篩檢
  • 藥物基因學檢測
  • 基於全基因組序列的DTC檢測
  • 其他
  • 市場分析:按分銷管道
  • 線上
  • 零售
  • 地域分佈
  • 市場分析:按地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 競爭訊息

  • 市場分析
  • 主要企業
  • 戰略分析

第 7 章 DTC(直接面對消費者)檢視的永續性:ESG 視角

  • ESG:概述
  • DTC 檢視產業的永續性:ESG 視角
  • 主要 ESG 議題
  • DTC檢測產業ESG績效分析
  • BCC的結語

第8章附錄

  • 調查方法
  • 來源
  • 縮寫詞
  • 公司簡介
  • 23ANDME INC.
  • ANCESTRY
  • GENETIC TECHNOLOGIES LTD.
  • EVERLYWELL INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MAPMYGENOME
  • MICROBIOME LABS
  • MYHERITAGE LTD.
  • QUEST DIAGNOSTICS INC.
  • VIOME LIFE SCIENCES INC.
Product Code: HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

The genetic DTC tests market for DTC testing is estimated to increase from $1.3 billion in 2023 to reach $2.7 billion by 2029, at a CAGR of 12.7% from 2024 through 2029.

The microbiome DTC tests market for DTC testing is estimated to increase from $51.3 billion in 2023 to reach $109.5 billion by 2029, at a CAGR of 13.7% from 2024 through 2029.

Report Scope

The current report provides detailed information about the direct-to-consumer (DTC) testing market. The report provides market projections for 2029 and market share for key market players. It details the market size of DTC testing based on test types, applications and distribution channels. Based on the test type, the DTC testing market is segmented into genetic DTC tests, biomarker-based DTC tests and microbiome DTC tests. The report excludes at-home pregnancy tests, fertility tests and COVID-19 tests. Provider-dependent at-home tests also are not included in this report. The report is segmented into health and wellness testing, ancestry and genealogy testing, carrier screening, disease risk assessment, pharmacogenetic testing, whole genome sequence-based DTC testing and other DTC tests based on application. Based on the distribution channel, the market is categorized into online and retail.

Report Includes

  • 21 data tables and 42 additional tables
  • Analysis of the global market landscape of direct-to-consumer (DTC) testing industry
  • Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimate of the current market size and revenue prospects, along with a market share analysis by test type, application, distribution channel and region
  • Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
  • An analysis of patents related to DTC
  • Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
  • An analysis of the industry structure, including companies' market shares, M&A activity, and venture funding
  • Company profiles of major players within the industry, including Ancestry, 23andMe Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., and MyHeritage Ltd.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • PESTEL Analysis
  • Porter's 5 Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential of New Entrants
  • Threat of Substitutes
  • Competition in the Industry
  • Regulatory Landscape
  • U.S.
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rising Consumer and Physician Awareness
  • Decreasing Costs of Genetic Sequencing
  • Market Restraints
  • Lack of Regulatory Guidelines
  • Inaccuracy of Results
  • Market Opportunities
  • Emerging Economies
  • Market Challenges
  • Ethical and Data Privacy Issues

Chapter 4 Emerging Technologies and Developments

  • Emerging Technologies
  • Advances in Gene Sequencing
  • Digitalization
  • Artificial Intelligence
  • Patent Analysis
  • Patents, by Company

Chapter 5 Market Segmentation Analysis

  • Segmental Breakdown
  • Market Analysis, by Test Type
  • Genetic DTC Tests
  • Biomarker-based DTC Tests
  • Microbiome DTC Tests
  • Market Breakdown, by Application
  • Health and Wellness Testing
  • Ancestry and Genealogy Testing
  • Disease Risk Assessment
  • Carrier Screening
  • Pharmacogenetic Testing
  • Whole Genome Sequence-based DTC Testing
  • Other DTC Tests
  • Market Breakdown, by Distribution Channel
  • Online Channel
  • Retail Channels
  • Geographic Breakdown
  • Market Analysis, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Market Analysis
  • Top Players
  • Strategic Analysis

Chapter 7 Sustainability in Direct-to-Consumer Testing: ESG Perspective

  • Introduction to ESG
  • Sustainability in Direct-to-Consumer (DTC) Testing Industry: An ESG Perspective
  • Key ESG Issues
  • DTC Testing Industry ESG Performance Analysis
  • Concluding Remarks from BCC

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • 23ANDME INC.
  • ANCESTRY
  • GENETIC TECHNOLOGIES LTD.
  • EVERLYWELL INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MAPMYGENOME
  • MICROBIOME LABS
  • MYHERITAGE LTD.
  • QUEST DIAGNOSTICS INC.
  • VIOME LIFE SCIENCES INC.

List of Tables

  • Summary Table : Global Market for DTC Testing, by Test Type, Through 2029
  • Table 1 : Comparison: DTC tests v/s Traditional Medical Tests
  • Table 2 : FDA Regulation of DTC Tests
  • Table 3 : DTC Genetic Tests: Ethical Issues
  • Table 4 : Patents, by Top Companies, 2022-2024
  • Table 5 : Global Market for DTC Testing, by Test Type, Through 2029
  • Table 6 : Global Market for Genetic DTC Tests, by Region, Through 2029
  • Table 7 : Global Market for Biomarker-based DTC Tests, by Region, Through 2029
  • Table 8 : Global Market for Microbiome DTC Tests, by Region, Through 2029
  • Table 9 : Global Market for DTC Testing, by Application, Through 2029
  • Table 10 : List of DTC Tests for Health and Wellness
  • Table 11 : Global Market for Health and Wellness DTC Testing, by Region, Through 2029
  • Table 12 : DTC Ancestry and Genealogy Tests
  • Table 13 : Global Market for Ancestry and Genealogy DTC Testing, by Region, Through 2029
  • Table 14 : Global Market for Disease Risk Assessment in DTC Testing, by Region, Through 2029
  • Table 15 : Global Market for Carrier Screening in DTC Testing, by Region, Through 2029
  • Table 16 : Global Market for Pharmacogenetic DTC Testing, by Region, Through 2029
  • Table 17 : List of WGS-based DTC Testing Companies, as of February 2022
  • Table 18 : Global Market for Whole Genome Sequence-based DTC Testing, by Region, Through 2029
  • Table 19 : Global Market for Other DTC Tests, by Region, Through 2029
  • Table 20 : Global Market for DTC Testing, by Distribution Channel, Through 2029
  • Table 21 : List of Some DTC Tests Available on Amazon
  • Table 22 : Global Market for Online Channel for DTC Testing, by Region, Through 2029
  • Table 23 : Global Market for Retail Channels for DTC Testing, by Region, Through 2029
  • Table 24 : Global Market for DTC Testing, by Region, Through 2029
  • Table 25 : DTC Testing: Market Player Share Analysis, 2023
  • Table 26 : Direct-to-Consumer Testing: Recent Developments, 2024
  • Table 27 : ESG Rankings for DTC Testing Companies, 2024*
  • Table 28 : ESG: Environmental Overview
  • Table 29 : ESG: Social Overview
  • Table 30 : ESG: Governance Overview
  • Table 31 : Report Sources
  • Table 32 : Glossary of Terms Used in Direct-to-Consumer Testing Market
  • Table 33 : 23andMe Inc.: Company Snapshot
  • Table 34 : 23andMe Inc.: Financial Performance, FY 2022 and 2023
  • Table 35 : 23andMe Inc.: Product Portfolio
  • Table 36 : 23andMe Inc.: News/Key Developments, 2021-2023
  • Table 37 : Ancestry: Company Snapshot
  • Table 38 : Ancestry: Product Portfolio
  • Table 39 : Ancestry: News/Key Developments, 2021-2023
  • Table 40 : Genetic Technologies Ltd.: Company Snapshot
  • Table 41 : Genetic Technologies Ltd.: Financial Performance, FY 2022 and 2023
  • Table 42 : Genetic Technologies Ltd.: Product Portfolio
  • Table 43 : Genetic Technologies Ltd.: News/Key Developments, 2021-2023
  • Table 44 : Everlywell Inc.: Company Snapshot
  • Table 45 : Everlywell Inc.: Product Portfolio
  • Table 46 : Laboratory Corporation of America Holdings: Company Snapshot
  • Table 47 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
  • Table 48 : Laboratory Corporation of America Holdings: Product Portfolio
  • Table 49 : Laboratory Corporation of America Holdings: News/Key Developments, 2023
  • Table 50 : MapmyGenome: Company Snapshot
  • Table 51 : MapmyGenome: Product Portfolio
  • Table 52 : Microbiome Labs: Company Snapshot
  • Table 53 : Microbiome Labs: Product Portfolio
  • Table 54 : MyHeritage Ltd.: Company Snapshot
  • Table 55 : MyHeritage Ltd.: Product Portfolio
  • Table 56 : Quest Diagnostics Inc.: Company Snapshot
  • Table 57 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
  • Table 58 : Quest Diagnostics Inc.: Product Portfolio
  • Table 59 : Quest Diagnostics Inc.: News/Key Developments, 2022-2023
  • Table 60 : Viome Life Sciences Inc.: Company Snapshot
  • Table 61 : Viome Life Sciences Inc.: Product Portfolio
  • Table 62 : Viome Life Sciences Inc.: News/Key Developments, 2022

List of Figures

  • Summary Figure : Global Market for DTC Testing, by Test Type, 2021-2029
  • Figure 1 : DTC Testing: Types
  • Figure 2 : DTC Testing: Advantages and Disadvantages
  • Figure 3 : DTC Testing: PESTEL Analysis
  • Figure 4 : Market Dynamics of DTC Testing
  • Figure 5 : Cost Per Genome, November 2017-May 2022
  • Figure 6 : Emerging Trends/Technologies in the DTC Testing Market
  • Figure 7 : Global Market Shares for DTC Testing, by Test Type, 2023
  • Figure 8 : Global Market Shares for DTC Testing, by Application, 2023
  • Figure 9 : Types of Genetic Ancestry Testing
  • Figure 10 : Global Market Shares for DTC Testing, by Distribution Channel, 2023
  • Figure 11 : Global Market Shares for DTC Testing, by Region, 2023
  • Figure 12 : North American Market for DTC Testing, 2021-2029
  • Figure 13 : European Market for DTC Testing, 2021-2029
  • Figure 14 : Asia-Pacific Market for DTC Testing, 2021-2029
  • Figure 15 : Rest of the World Market for DTC Testing, 2021-2029
  • Figure 16 : DTC: Market Player Share Analysis, 2023
  • Figure 17 : DTC Testing: Recent Developments, by Category, 2024
  • Figure 18 : ESG Pillars
  • Figure 19 : Advantages of ESG for Companies
  • Figure 20 : ESG Penetration, DTC Testing Market, 2024
  • Figure 21 : Methodology Used in Direct-to-Consumer Testing Market
  • Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 23 : 23andMe Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 24 : Genetic Technologies Ltd.: Revenue Shares, by Business Unit, FY 2023
  • Figure 25 : Genetic Technologies Ltd.: Revenue Shares, by Country/Region, FY 2023
  • Figure 26 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
  • Figure 27 : Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023